Back to News
Market Impact: 0.15
TETRAPHARM appoints Rolf Sass Sørensen as Chief Executive Officer
Source: PRWeb
Management & GovernanceHealthcare & Biotech
TETRAPHARM appointed Rolf Sass Sørensen as Chief Executive, succeeding co-founder Martin Rose. Rose and co-founder Jesper Breum are moving on to pursue new biotech ventures while remaining shareholders in TETRAPHARM.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- ‘I drive a Tesla’: After Elon Musk said he’d lose his job, Delta CEO Ed Bastian says there’s ‘no tit for tat’ as airline unveils earnings miss
- Trump created a committee to dig into the Fed's Lisa Cook. What is it and what comes next?
- ‘Indentured servants’: US green card move will hit thousands of IT workers
- Teva wins FDA approval for monthly schizophrenia injection Weltruza
- BofA downgrades Alignment Healthcare stock rating on star rating drop
- Trump launches probe into Federal Reserve Governor Lisa Cook
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Eli Lilly Q4 2025 Earnings: Revenue Surges 43% as Mounjaro and Zepbound Dominate the GLP-1 Market
- Investment Research Software Costs: A 2026 Budget Framework